Family Medicine · Watertown, SD
NPI
1730147125
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
511 14th Ave NE
Watertown, SD, 57201
Phone (605) 886-8482
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
3,962 services
Medicare patients, 2024
259
Average age 70
Drug cost, 2024
$785K
8,508 prescriptions
Company payments, 2025
$662
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan M McAreavey was code 99490 (chronic, principal, and transitional care management), 407 times for 87 patients. In total Jonathan M McAreavey billed 3,962 services in 124 codes, and Medicare paid $137K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-17.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 407 | 87 | $48.10 | $20K |
| 36415 Venipuncture Blood Collection | Office | 346 | 204 | $8.60 | $2,977 |
| 80061 Clinical Chemistry | Office | 188 | 174 | $12.98 | $2,440 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 183 | 183 | $15.08 | $2,759 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 182 | 182 | $130.98 | $24K |
| 99214 Office E&M - Established | Office | 178 | 124 | $90.38 | $16K |
| 80053 Clinical Chemistry | Office | 176 | 161 | $10.29 | $1,811 |
| 99215 Office E&M - Established | Office | 173 | 160 | $110.96 | $19K |
| 80048 Clinical Chemistry | Office | 131 | 95 | $8.29 | $1,086 |
| 83036 Blood Count | Office | 118 | 63 | $9.44 | $1,114 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | Office | 96 | 96 | $18.92 | $1,816 |
| 99213 Office E&M - Established | Office | 79 | 66 | $51.78 | $4,090 |
| 84443 Clinical Chemistry | Office | 64 | 54 | $16.46 | $1,053 |
| 84439 Clinical Chemistry | Office | 55 | 47 | $8.84 | $486 |
| 82043 Clinical Chemistry | Office | 45 | 43 | $5.53 | $249 |
By year: 2022 $129K for 3,839 services; 2023 $119K for 6,295 services; 2024 $137K for 3,962 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 346 | 204 | $8.60 | $2,977 |
| 80061 Clinical Chemistry | 188 | 174 | $12.98 | $2,440 |
| 80053 Clinical Chemistry | 176 | 161 | $10.29 | $1,811 |
| 80048 Clinical Chemistry | 131 | 95 | $8.29 | $1,086 |
| 83036 Blood Count | 118 | 63 | $9.44 | $1,114 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 96 | 96 | $18.92 | $1,816 |
| 84443 Clinical Chemistry | 64 | 54 | $16.46 | $1,053 |
| 84439 Clinical Chemistry | 55 | 47 | $8.84 | $486 |
| 82043 Clinical Chemistry | 45 | 43 | $5.53 | $249 |
| 85025 Blood Count | 38 | 36 | $7.61 | $289 |
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan M McAreavey prescribed most often to Medicare patients was Levothyroxine Sodium, with 411 prescriptions and refills. In total Jonathan M McAreavey wrote 8,508 Medicare prescriptions that cost $785K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 411 | 993 | 86 | $3,796 |
| Atorvastatin Calcium Generic | 394 | 1,033 | 102 | $2,142 |
| Lisinopril Generic | 305 | 771 | 77 | $1,604 |
| Amlodipine Besylate Generic | 289 | 675 | 69 | $1,500 |
| Omeprazole Generic | 264 | 543 | 57 | $1,944 |
| Metoprolol Succinate Generic | 258 | 681 | 68 | $3,193 |
| Tamsulosin Hcl Generic | 217 | 518 | 55 | $2,960 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 207 | 516 | 51 | $840 |
| Simvastatin Generic | 190 | 538 | 53 | $981 |
| Hydrochlorothiazide Generic | 190 | 420 | 44 | $543 |
| Escitalopram Oxalate Generic | 184 | 412 | 42 | $2,154 |
| Pantoprazole Sodium Generic | 183 | 405 | 45 | $1,871 |
| Gabapentin Generic | 164 | 313 | 40 | $1,943 |
| Furosemide Generic | 141 | 274 | 32 | $588 |
| Allopurinol Generic | 133 | 359 | 34 | $1,089 |
Brand drugs: 939 claims; generic drugs: 7,543 claims; opioid claims: 267.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan M McAreavey $662 ($662 in general payments such as food, travel and fees) from 11 companies. The largest payer was Pfizer Inc. with $196.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 18 | $196 |
| Abbvie Inc. ABBV | 13 | $159 |
| Amgen Inc. AMGN | 5 | $84.26 |
| Lilly USA, LLC LLY | 4 | $71.02 |
| Collegium Pharmaceutical, Inc. COLL | 2 | $31.21 |
| Exact Sciences Corporation EXAS | 2 | $30.87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $19.99 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $19.65 |
| Abbott Laboratories ABT | 1 | $19.15 |
| Merck Sharp & Dohme LLC MRK | 1 | $17.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.